19Dec
As its COVID-19 Vaccine Nears Finalization, AstraZeneca Announces Deal to Buy Alexion for $39 Billion
AstraZeneca, the British-Swedish multinational pharmaceutical company currently collaborating with the University of Oxford on a COVID-19 vaccine, will purchase Alexion Pharmaceuticals for $39 billion. The transaction, which awaits approval by shareholders and regulators, is the largest purchase by a health care company this year and is expected to close in the third quarter of 2021. Alexion was founded in 1992 and is headquartered in Boston but has a global presence. It is known for its...
By:
Rothwell, Figg, Ernst & Manbeck, P.C.
Related
The year 2020 is already shaping up to be quite active on the employment law front, and a quarter of...
Read More >
On 31 December 2019, a new coronavirus disease, now officially named “Covid-19”, was first reporte...
Read More >
Illinois employers must begin preparing now for the host of new legal requirements impacting the wor...
Read More >
Under Arizona law, when a purchaser of a new residential dwelling unit alleges a construction defect...
Read More >
In a bipartisan 251 to 158 vote, the House of Representatives passed H.R. 1309, which would require ...
Read More >
The NSW Parliament passed the Design and Building Practitioners Act 2020 (NSW) (the Act) on 11 June ...
Read More >